“genentech” Archives

in
Entry Author Date Location
On ASCO’s Eve, Experts Fret Over Backlash To Cancer Combo Frenzy 05/30/17 National
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Merck Immunotherapy Drug Notches Another FDA Win in Lung Cancer 05/11/17 New York
Stalled or Rising Momentum? New York Wrestles With Its Biotech Future 05/10/17 New York
Genentech Drug Fails to Beat Chemo in Treating Advanced Bladder Cancer 05/10/17 San Francisco
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
First Trial Underway, CytomX Gets $200M More In Expanded Bristol Pact 03/20/17 San Francisco
No Details Yet, But Genentech Drug Combo Wins in Big Breast Cancer Study 03/02/17 San Francisco
Join Xconomy in June for ‘What’s Hot In Cancer Immunotherapy 2017’ 03/01/17 Seattle
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
Ophthotech Eye Drug Fails Badly in Pivotal Test, Shares Crumble 12/12/16 New York
Verastem Takes a Low-Cost Flier on Infinity’s Blood Cancer Drug 11/02/16 Boston
On Front Lines Of Price Dispute, Eye Doctors Wary of New Drug Data 11/01/16 National
BlackThorn Emerges With $40M, New Weapons Against Neuro Disorders 10/20/16 San Francisco
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
New Rockefeller Prez Takes Stock of “Wildly Underdeveloped” NY Bio Scene 09/27/16 New York
Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More 09/23/16 National
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
Page 1 of 19 next page »